Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Romainy, and I'll prepare your conference operator today.
Prestige Consumer Healthcare Inc. (PBH)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ariel Investments John W. Rogers | 2,835,203 | $195,203,726 | +11% | 2.11% |
| 2. | Renaissance Technologies Jim Simons | 373,802 | $25,736,268 | +5% | 0.04% |
| 3. | Fisher Asset Management Ken Fisher | 317,241 | $21,842,042 | +2% | 0% |
| 4. | Impax Asset Management Ian Simm | 170,000 | $11,704,500 | 0.04% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 123,920 | $8,531,892 | +7% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.90 | 1,500 | Officer | 6,600 | 2018-02-12 | Filing | |
| $37.04 | 3,000 | Director | 7,806 | 2018-02-07 | Filing | |
| $35.47 | 4,200 | Director | 11,097 | 2018-02-05 | Filing | |
| $35.94 | 7,000 | Officer | 138,969 | 2018-02-05 | Filing | |
| $35.47 | 7,500 | Director | 38,506 | 2018-02-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $70.41 | 110 | Officer | 15,934 | 2024-03-01 | Filing | |
| $70.43 | 62 | Officer | 15,934 | 2024-03-01 | Filing | |
| $70.36 | 416 | Officer | 15,934 | 2024-02-28 | Filing | |
| $70.19 | 246 | Officer | 15,934 | 2024-02-28 | Filing | |
| $70.00 | 1 | Officer | 15,934 | 2024-02-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,068,544 | $555,176,263 | 0.01% | |
| 2. | 5,756,138 | $352,390,769 | 0% | |
| 3. | 3,434,466 | $210,259,692 | 0.06% | |
| 4. | 3,062,622 | $187,494,000 | 0.21% | |
| 5. | 2,002,485 | $122,592,132 | 0% |
News See All
Should You Invest in Prestige Consumer Healthcare (PBH)?
Ariel Investments, an investment management company, released its “Ariel Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2024 Prestige Consumer Healthcare Earnings Conference Call.
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q1 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Q1 2024 Prestige Consumer Healthcare, Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode.
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Prestige Consumer Healthcare Fiscal 2023 Earnings Call.
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Q3, 2023 Prestige Consumer Healthcare Inc, Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Stocks to Buy in 2022 According to John Rogers' Ariel Investments
In this article, we discuss 10 Stocks to Buy in 2022 According to John Rogers' Ariel Investments.
10 Cheap Healthcare Stocks To Buy Now
In this article we discuss 10 cheap healthcare stocks to buy now.
Is PBH A Good Stock To Buy Now?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Hedge Funds Are Warming Up To Prestige Consumer Healthcare Inc. (PBH)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Billionaire Hedge Funds
